Tilray (NASDAQ:TLRY)

  • Symbol:NASDAQ:TLRY
  • Sector:Healthcare
  • Industry:Pharmaceutical
  • CEO:Brendan Kennedy
  • Founded:2015
Categories:

Tilray (NASDAQ:TLRY) Stock Price

Tilray (NASDAQ:TLRY) Company Overview

Tilray Inc (NASDAQ:TLRY) is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids, and currently serves tens of thousands of patients and consumers, in 13 countries spanning five continents. The company operates an asset-light model, meaning that it prefers to spend its capital further down the value chain. 

And the further down the value chain you go, the closer you come to the brands and consumers. And for Tilray it's all about the brands. The company is brand-centric across both its medicinal and recreational cannabis markets.

Tilray made history in September 2018, when it became the first Canadian cannabis company to legally export medical cannabis to the U.S. for a clinical trial. Its medicinal brands are now imported into 13 countries with that number set to double in the coming 24 months.

The company has gone from strength to strength, and last year signed a deal with Novartis AG's subsidiary Sandoz to sell, distribute and co-brand Tilray's non-smokeable/non-combustible medical cannabis products in medicinally legal markets worldwide.

In order to take advantage of Canada becoming only the second country in the world to legalise cannabis for adult-use, TLRY announced the launch of the High Park Company – a recreationally-focussed company supplying various brands and form factors in the market.

High Park in a joint venture with AB InBev, founded Fluent, which will target the cannabis beverages market – one that has great excitement and optimism associated with it. Tilray also did a deal with the Authentic Brands Group (ABG) whereby they become the exclusive supplier of CBD-derived and infused products, which can then be distributed through the various brands in the ABG's portfolio.

Tilray's European base is in Portugal where they have a 2.5 million square foot facility that will be their production hub for the distribution of their product into Europe and globally. Tilray also recently partnered with Cannamedical Pharma GmbH, through its wholly-owned subsidiary, Tilray Portugal, to export a wholesale shipment of USD$3.3 million worth of medical cannabis from Portugal to Germany.

Tilray opened the US up with its acquisition of Manitoba Harvest, a hemp food company, that supplies nearly 70% of the US's hemp food. This acquisition gave them immediate access to 13,500 retail outlets across the US, including Walmart and Costco. Tilray has now launched a hemp-derived CBD range that will be distributed through the Manitoba network.

Tilray (NASDAQ:TLRY) Financials

More From Tilray...

Hitting it Out of the Park – Cresco Labs Acquires Gloucester and Lists on Frankfurt Stock Exchange
Tilray Revenue Up 371% From Previous Year in Q2 Financial Results
Tilray Imports CBD to be Studied at NYU Medical School
Higherland: Ireland Becomes 13th Country to Receive Tilray Products
Cannabis Coup – CEO Bruce Linton Axed from Canopy Growth
The Edibles, Extracts and Concentrates Market
Tilray Expands European Leadership Team with Five Senior Appointments
June 2019 – Cannabis Stocks still Under Pressure from the Bears
Bowling a Double – Canopy Growth Corporation Strikes Again
Tilray Imports Cannabis Products to UK
Load More Results

Investor Presentation

The latest update from the company

Click Here
Stay updated about
this company

Signup to get updates.

Management

Brendan Kennedy
Chief Executive Officer
Brendan Kennedy has served as our President and Chief Executive Officer and member of the board of directors since January 2018 and has served as the Chief Executive Officer and member of the board of directors of its subsidiary, Tilray Canada Ltd., since 2013. Mr. Kennedy also serves as the Executive Chairman and member of the board of directors of Privateer Holdings, a private investment firm focused exclusively on the cannabis industry, since he founded it in October 2011.

Mr. Kennedy served as Chief Executive Officer of Privateer Holdings from its founding until June 2018. Prior to founding Privateer Holdings, Mr. Kennedy served as the Chief Operating Officer of Silicon Valley Bank Analytics from 2010 to 2011 and Managing Director from 2006 to 2010. Mr. Kennedy holds a BA from the University of California, Berkeley, an MS in Engineering from the University of Washington and an MBA from the Yale School of Management.
Mark Castanda
Chief Financial Officer
Mark Castaneda has served as the Chief Financial Officer, Secretary and Treasurer since March 2018. Mr. Castaneda previously served as the Chief Financial Officer and Assistant Treasurer of Primo Water Corporation, a publicly-traded water marketing and distribution company, from March 2008 to January 2018.

From October 2007 to March 2008, Mr. Castaneda served as the Chief Financial Officer for Tecta America, a private national roofing contractor, and from October 2004 to August 2006, he served as Chief Financial Officer for Pike Electric Corporation, a publicly-traded energy solutions provider, where he helped lead its initial public offering in July 2005.

Mr. Castaneda began his career with Deloitte & Touche in 1988 and is a certified public accountant. Mr. Castaneda has served on the Audit Committee of Ranir Global Holdings since August 2016. Mr. Castaneda holds a BS in Accountancy and a Masters, Taxation from DePaul University.
Andrew Pucher
Chief Corporate Development Officer
Andrew joined Tilray in March 2019 from Goldman Sachs, where he was a Managing Director and most recently served as Head of Canadian Diversified Investment Banking, which included coverage of the Canadian cannabis industry.

Previously, he was a member of Goldman Sachs’ Global Healthcare Investment Banking Group in New York, where he advised on more than $200 billion in announced M&A and financing transactions, with a focus on the biopharmaceutical sector.

Andrew leads Tilray’s corporate development function, including the team that is responsible for M&A and corporate investments.
Chrstine St. Clare
Non-Executive Director
Christine St.Clare founded St.Clare Advisors, LLC in September 2010 and currently serves as its President. Prior to founding her own firm, Christine was a partner at KPMG LLP, where she was an Audit Partner from 1986 to 2005 and Advisory Partner from 2006 to 2010. During her time at KPMG, Christine served as Lead Audit Partner for some of the firm’s largest retail clients and served a four-year term on KPMG’s Board of Directors.

She currently is an Independent Director of Fibrocell Science, Inc., and AquaBounty Technologies, Inc. and was an Independent Director for AVINTIV, Inc. (formerly known as Polymer Group, Inc.) prior to the sale of the company.
Rebekah Dopp
Non-Executive Director
Rebekah Dopp is Principal, News and Local Media – Global Partnerships at Google. She joined the company in September 2016 as Head of Local TV Partnerships for YouTube TV. Prior to joining Google, Rebekah was Senior Vice President, Advanced Services for CBS Corporation (CBS).

She began her media career at Home Box Office, Inc. (HBO) where she spent 14 years in leadership positions in technology and distribution, culminating in her role as Vice President, Global Technology Business Management.

Rebekah has led global teams negotiating complex agreements with domestic and international technology partners and affiliates and was on the launch teams for streaming TV services HBO GO, CBS All Access, and YouTube TV.